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Abstract
Background Medication errors are a major public health concern that negatively impact patient safety and health outcomes. 
Effective and efficient medication error reporting systems and practices are imperative in reducing error incidence and 
severity. Objective The objectives were to quantify the incidence, nature and severity of medication errors, and to explore 
potential causality using a theoretical framework. Setting The study was conducted at Hamad Medical Corporation, the 
largest public funded academic healthcare center in the state of Qatar. Methods A retrospective review of medication error 
reports submitted to the Hamad Medical Corporation incident reporting system during 2015 to 2017. Data related to number 
of reports, reporter, medication, severity and outcomes were extracted. Reason’s Accident Causation Model was used as a 
theoretical framework for identifying potential causality. Two researchers independently categorized errors as: active failures 
(e.g. forgetting to administer medication at scheduled time); error provoking conditions (e.g. medication prescribed by an 
unauthorized physician and administered to the patient); and latent failures (e.g. organizational factors, lack of resources). 
Main outcome measures Incidence, classes of medications, reporter, error severity and outcomes, potential causality. Results 
A total of 5103 reports provided sufficient information to be included in the study giving an estimated error incidence of 
0.044% of prescribed medication items. Most of the reports (91.5%, n = 4667) were submitted by pharmacists and majority 
(87.9%, n = 4485) were prescribing errors. The most commonly reported medications were anti-infectives for systemic use 
(22.0%, n = 1123) followed by medications to treat nervous system disorders (17.2%, n = 876). Only three errors reported 
to have caused temporary harm requiring intervention while one contributed to or resulted in temporary harm requiring 
initial or prolonged hospitalization. In terms of potential causality of medication errors, the majority (91.5%, n = 4671) were 
classified as active failures. Conclusion Almost all reports were submitted by pharmacists, indicating likely under-reporting 
affecting the actual incidence. Effort is required to increase the effectiveness and efficiency of the reporting system. The use 
of the theoretical framework allowed identification of potential causality, largely in relation to active failures, which can 
inform the basis of interventions to improve medication safety.
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Impacts on practice
• There is a need to improve the information supplied 
by healthcare professionals when submitting an error 
report.
• Accumulation of evidence around error causality using 
Reason’s Accident Causation theory will be useful 
in considering any potential interventions aiming to 
reduce these factors.
• Identifying behavioural determinants in relation to 
error reporting will help establish a better error report-
ing system.
Introduction
Medication errors are highly prevalent, occurring at any 
stage of the medication use processes including prescrib-
ing, dispensing, medication administration and monitor-
ing [1–5]. In March 2017, the World Health Organization 
(WHO) launched the third global patient safety challenge, 
‘Medication Without Harm’ [6], following on from the 
first two challenges of, ‘Clean Care is Safer Care’ [7], 
and ‘Safe Surgery Saves Lives’ [8]. The third challenge 
aims to, ‘drive a process of change to reduce patient harm 
generated by unsafe medication practices and medication 
errors’. Medication errors are preventable, as highlighted 
in the most commonly cited definition of the National 
Coordinating Council for Medication Error Reporting 
and Prevention (NCCMERP) in the United States, ‘any 
preventable event that may cause or lead to inappropriate 
medication use or patient harm, while the medication is 
in the control of the health care professional, patient, or 
consumer’ [9].
A number of systematic and narrative reviews have 
sought to quantify mediation errors and the subcategories 
of prescribing, administration and dispensing errors [3, 
10]. Ross et al. aimed to quantify prescribing errors com-
mitted by junior doctors, reporting that errors occurred at 
a rate of 2 to 514 per 1000 items prescribed and 4.2–82.0% 
of patient charts [11]. The systematic review of Lewis 
et al. on the prevalence, incidence and nature of prescrib-
ing errors in hospital inpatients yielded a median error 
rate [interquartile range (IQR)] of 7% (2–14%) of medi-
cation orders, 52 (8–227) errors per 100 admissions and 
24 (6–212) errors per 1000 patient days [2]. Focusing on 
medication administration errors, Keers et al. reported a 
median error rate of 18.8% (IQR 4.9–23.5%) including 
with timing errors and 7.4% (5.2–9.8%) without [12]. Sev-
eral systematic reviews have focused on studies conducted 
in the Middle East. In 2013, Alsulami et al. reviewed the 
incidence, types of medication errors and main contribu-
tory factors in Middle Eastern countries. While noting that 
error rates were difficult to compare due to being expressed 
differently, prescribing errors ranged from 7.1% of pre-
scriptions in a teaching hospital to 90.5% of prescriptions 
in a primary healthcare centre. Poor medication knowledge 
was identified as a major contributory factor for errors [3]. 
In 2018, Alsaidan et al. reviewed studies which originated 
in the six countries of the Gulf Cooperation Council (Bah-
rain, Kuwait, Oman, Qatar, Saudi Arabia, The United Arab 
Emirates) giving a prescribing error rate of 8.5–16.9/100 
admissions [13]. Later, Thomas et al. synthesized data 
on the prevalence, nature, severity and causes of medica-
tion errors in hospital settings in the Middle East. Pre-
scribing errors were the most commonly studied, with a 
median error rate of 10% (IQR 2–35%). The review further 
reported that causes of medication errors were multifac-
torial and that a standardised, theory-informed approach 
should be adopted in primary research to ensure that all 
possible explanations underlying medication errors could 
be identified [10].
Reason’s Accident Causation model is the most com-
monly applied theoretical framework in identifying and 
addressing medication errors [14]. This model categorises 
error causes as active failures, error-producing conditions 
and latent failures. Active failures are unsafe acts commit-
ted by those in direct contact with the patient or system. 
These failures take a variety of forms including slips and 
lapses (errors in task execution), mistakes (errors in plan-
ning) and procedural violations (rule breaking). Error-pro-
ducing conditions include those within the local workplace 
(e.g. time pressure, understaffing, inadequate equipment, 
fatigue and inexperience). Latent failures arise from deci-
sions made by policy makers, leaders and top-level man-
agement [15]. Review of errors within these categories 
should stimulate reflection on practice at the individual 
and organisational levels in an attempt to eliminate further 
similar errors.
Effective and efficient medication error reporting sys-
tems are therefore of paramount importance to promote 
staff engagement; quality, timely and consistent reporting; 
and feedback to impact organisations and practitioners, 
and thus enhance patient safety [9, 16]. The strategic aims 
of NCCMERP highlight the value of effective and effi-
cient medication error reporting systems and practices in 
reducing error prevalence and severity [9]. Goals include: 
stimulating the development and use of medication error 
reporting systems by healthcare organisations,and stimu-
lating the review and analysis of error reports leading to 
the development of recommendations to reduce, and ulti-
mately prevent, errors.
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Aim of the study
The aims of the study were to quantify the incidence, nature 
and severity of medication errors reported within Hamad 
Medical Corporation (HMC), Qatar, and to explore potential 
causality using Reason’s Accident Causation model.
Ethics approval
The study was approved in September 2018 by the Institu-
tional Ethics Committee and Medical Research Center at 
HMC (MRC-01-18-109).
Methods
This was a cross-sectional, retrospective chart review study 
of all medication errors submitted by health professionals 
during the period of January 2015 to December 2017 (i.e. 
36 months).
Setting
This study was conducted at the largest academic healthcare 
center in the state of Qatar. With more than 2300 inpatient 
beds, HMC is the primary provider of secondary and ter-
tiary healthcare in the country. HMC manages 12 hospitals, 
(nine specialist hospitals and three community hospitals), 
the National Ambulance Service and home and residential 
care services [17].
Medication error reporting at HMC
HMC’s medication error reporting policy has adopted the 
NCCMERP definition of medication error, with health pro-
fessionals mandated to report all medication errors and near 
misses, irrespective of severity or consequence [18]. A ‘near 
miss’ is defined within the policy as, ‘an event or situation 
that could have resulted in an accident, injury, or illness, 
but did not, either by chance or through timely interven-
tion’. HMC advocates reporting all types of errors, and the 
importance of medication error reporting has been explained 
to all staff during orientation and also during periodic edu-
cation and training in the form of lectures, seminars and 
conferences etc.
The medication error reporting system is electronic, with 
all reports being reviewed by the HMC Quality Management 
Department. Quarterly and annual reports on medication 
errors and near misses, including action taken, are shared 
with HMC Quality and Patient Safety Committee, and HMC 
Pharmacy and Therapeutic Committee [18]. The medication 
error reporting process is described in Fig. 1.
RL6 incident reporting system
RL6 is a web-based online reporting system adapted by 
HMC for voluntarily reporting of medication errors by 
health professionals using a standardized format. An elec-
tronic form captures details of, reporter; date and time of 
error; area (inpatient/outpatient); hospital; patient details; 
staff involved; description of the error; medications involved; 
type of error (prescribing, dispensing etc.); severity of error; 
and contributory factors [19].
Medicaon error Time span Review & Feedback Collaon & Analysis Intervenon and 
disseminaon
Inform the immediate 
supervisor about 
medicaon errors for 
appropriate acons  
Completed report forwarded 
to the hospital pharmacy 
department & the quality 
department for further review 
and feedback
Hospital QPS commiee 
discusses significant errors 
and takes necessary acons to 
minimise such errors in future 
Summary of the reports, 
relevant acons taken 
are disseminated to 
Corporate QPS, P&T & 
MoPH
Reports from all hospitals 
are forwarded to 
medicaon safety and 
quality center for 
synthesis and analysis 
The person who discovers 
must report to the 
electronic reporng 
system within 24hrs
Fig. 1  Medication error reporting process at Hamad Medical Corporation, Qatar
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Analysis
All reports were extracted from the RL6 database using IBM 
SPSS Statistics for Windows, Version 20.0. Data cleaning 
was performed, and multiple reports of the same event were 
counted as one; if the same error was reported by multiple 
health professionals, only the first report was included.
The incidence of medication errors was calculated using 
the formula,
The total number of medications ordered over the study 
period was generated by Cerner, an internationally accepted 
health information technology used in more than 27,000 
healthcare facility across the world. It is an integrated data-
base that electronically stores, captures and accesses patient 
health information. One medication ‘order’ represents each 
medication item prescribed to an individual patient, irre-
spective of dose, route, duration etc. The following were data 
also extracted: the specific medication categorized accord-
ing to the WHO Anatomical Therapeutic Chemical (ATC) 
classification [20], profession of the reporter,and severity 
assessed by the reporter using the NCCMERP approach of 
classification into four levels and nine severity categories 
ranging from potential for error (category A) to actual error 
that may have contributed to or resulted in a patient’s death 
(category I) [21]. These data were analysed using descriptive 
statistics of frequency and percentage.
The free text data on contributory factors (potential cau-
sality) of medication errors recorded by the reporter were 
independently analysed by two researchers experienced in 
the assessment of medication error reports. Instances of non-
consensus were referred to one of two other experienced 
assessors for final judgement. Each researcher applied Rea-
son’s Accident Causation Model as a framework [15], cat-
egorizing potential causality as: active failures,error provok-
ing conditions,or latent failures. These were sub-classified 
by the researchers according to the most commonly recur-
ring groupings.
Results
Over the three-year study period, 18,390 incidents were 
reported, of which 2130 were excluded as duplicates and 
a further 2720 excluded as not deemed errors (e.g. out of 
stock medication and non-preventable adverse drug reac-
tions). During the same period, there were 30,650,000 medi-
cation orders giving a reported medication error incidence 
of 0.044%.
Of the 13,540 reports, 6237 were excluded from further 
analysis as having incomplete information (e.g. error type, 
Incidence =
Total number of medication errors reported
Total number of medications ordered
× 100%
severity) and a further 2200 with no or almost no free text 
description of the error. Only 5103 unique reports (37.7%) 
had sufficient information to be included in the remaining 
stages of analysis. Figure 2 is a flowchart of the fate of the 
medication error reports in this study.
The majority of the reports (91.5%, n = 4667) were sub-
mitted by pharmacists followed by nurses (7.6%, n = 388) 
with very few (0.2%, n = 11) by doctors. Most reports 
(87.9%, n = 4485) were prescribing errors, with less admin-
istration errors (6.3%, n = 322), dispensing errors (5.1%, 
n = 260) and monitoring errors (0.7%, n = 36). The most 
common prescribing errors were wrong dose (36.1%, 
n = 1619), wrong frequency (14.6%, n = 658) and duplica-
tion (two or more medications from the same pharmacologi-
cal grouping) (11.3%, n = 510). Medications were classified 
according to the Anatomical Therapeutic Chemical (ATC) 
classifications and anti-infectives for systemic use (22%, 
n = 1123) were the most common followed by medications 
used to treat nervous system disorders (17.2%, n = 876) (see 
Fig. 3).
According to the reporter, most reports (77.3%, n = 3,43) 
were either NCCMERP Category A (circumstances or 
events that have the capacity to cause error), followed by 
Category C (14.3%, n = 731) (an error occurred that reached 
the patient but did not cause patient harm), Category D 
(5.9%, n = 301) (an error occurred that reached the patient 
and required monitoring to confirm that it resulted in no 
harm to the patient and/or required intervention to preclude 
harm) and Category B (2.4%, n = 124) (an error occurred 
but the error did not reach the patient). Three errors (0.06%) 
were classified as Category E (wherein an error occurred and 
may have contributed to or resulted in temporary harm to the 
patient and required intervention) and only one error (0.02%) 
Category F (contributed to or resulted in temporary harm to 
the patient and required initial or prolonged hospitalization).
All 5104 error reports were analysed according Rea-
son’s Accident Causality Model. Almost all (91.5%, 
n = 4671) were classified as active failures, of which com-
prised mistakes (66.1%, n = 3087), slips (16.6%, n = 774), 
lapses (12.7%, n = 593) and violations (4.6%, n = 217). The 
remainder were classified as error provoking conditions 
(8.4%, n = 429) and latent failure (0.04%, n = 2). The sub-
classifications of these categories are given in Table 1. Note 
that many reports could not be classified due to incomplete 
information.
Discussion
The estimated incidence of medication errors in this study, as 
derived from medication error reports was 0.044%. Almost 
all reports were submitted by pharmacists for prescribing 
errors, which were largely wrong dose or wrong frequency 
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errors. Most errors were considered by the reporter to be 
minor in nature. According to Reason’s Accident Causal-
ity Model [15], the vast majority were considered as active 
failures (slips, lapses, mistakes and violations).
Both NCCMERP and HMC have strategic aims that high-
light the value of effective and efficient medication error 
reporting systems and practices in reducing error preva-
lence and severity [9, 18]. The findings of this study pro-
vide evidence that the reporting system and processes at 
HMC require review. Of the reports extracted, around one 
fifth were either duplicate reports or reports for incidents not 
classified as medication errors. Furthermore, of the remain-
ing reports, just over one third had sufficient details to be 
included in the study. Of note, these reports can then not be 
used for the purpose of reflecting on healthcare practices 
hence will not contribute to improved patient safety. Several 
studies in other settings have also highlighted the issue of 
incomplete reports [22–24].
The incidence of medication errors, as identified in this 
study, is low compared to the figures reported in a recent 
systematic review wherein medication errors reported varied 
from 0.18 to 56 per 100 medication orders [10]. Various 
reasons could be attributed to these differences, most likely 
differences in error definitions, methodological approaches 
and outcome measures. Of the nine studies in the review 
which reported data derived from medication error reports, 
there was a lack of inconsistency in presentation of results 
[10]. Studies used terms of ‘errors per 1,000 admissions’, 
‘errors per 100 prescriptions’, ‘errors per 1000 patient days’ 
etc., which limits any direct comparisons. There is a need to 
agree defined method and reporting standards for all such 
studies to facilitate data pooling, comparison and learning 
from best practice. Such developments would align to the 
aspirations of the WHO, ‘Medication Without Harm’ [1], 
and also provide a standardised benchmark for determining 
the impact of any interventions.
There are other complications to the interpretation of 
incidence data, which are likely to compromise its validity. 
To be valid, all medication errors have to be identified and 
promptly reported. There is accumulated evidence of wide-
spread and significant under-reporting of medication errors 
by healthcare profession [25–32]. A recent mixed methods 
study conducted in Qatar identified a number of barriers 
to error reporting including fear and worry,that submitting 
was likely to lead to further investigation,concerns over the 
impact on working relationships,and the potential lack of 
confidentiality [16]. The incidence data derived from this 
study can therefore only be considered an estimate of the 
Fig. 2  Inclusion and exclusion 
of medication errors for the 
final analysis







Total number of medicaon errors 





Excluding reports not defined as
medicaon errors = 2720
Excluding reports with incomplete 
informaon
n = 6237
Excluding reports with insufficient 
free text informaon describing the 
medicaon error
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true incidence of medication errors in HMC. It is notable 
that almost all medication error reports were submitted by 
pharmacists, indicating potentially marked under-reporting 
by nurses and doctors.
While most errors were categorised as no harm, the sever-
ity rating was undertaken solely by the reporter hence may 
have been subjected to biases including reporting and social 
desirability. Rating the severity of medication errors is not 
straightforward hence the validity of these findings may 
be questionable. A systematic review of the tools used to 
assess prescribing error severity in studies reporting hospital 
prescribing error rates highlighted that 57% of 107 studies 
included in the review had an assessment of severity. While 
40 different tools were identified, only two were considered 
to have acceptable reliability and validity [33]. While it may 
be useful for the reporter in HMC to consider the severity 
and consequences of the error, the potential validity issues 
should be borne in mind.
One strength of this study was the application of Rea-
son’s Accident Causality Model in analysing the narra-
tive description of the reports. While the findings will be 
dependent on the richness of the narrative (and in many 
instances this was incomplete), this does provide some 
indication of causality. Almost all errors were consid-
ered to be active failures (slips, lapses, mistakes and vio-
lations). The systematic review of medication errors in 
hospitals in the Middle East synthesised findings accord-
ing to Reason’s Accident Causation Model, with similar 
results of active failures of slips, lapses and mistakes being 
most common [10]. Similar findings have been reported 
in systematic reviews of studies not restricted to the Mid-
dle East. In a review of prescribing errors in hospitalised 
patients, Tully et al. reported that the active failures were 
most frequently cited [34], as did Keers et al. in a system-
atic review of medication administration error studies [35].
This accumulation of evidence around active failures will 
be useful in considering any potential interventions aiming 
to reduce these factors. One limitation of Reason’s model 
is that it does not describe the full range of behavioural 
determinants potentially leading to errors occurring. While 
the research team had considered applying a behavioural 
change theoretical framework to characterize behavioural 
determinants, this could not be undertaken due to the lack 
of detailed information contained within the reports. The 
development of standardized reporting criteria to include 
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Total number of errors 
reported = 5103
Fig. 3  Drug categories associated with medication errors (%)
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the development of targeted interventions aiming to reduce 
medication errors.
This study has several strengths including analysis of data 
collected over a three year period and the application of a 
theoretical framework within the study. There are, however, 
a number of study weaknesses hence the findings should 
be interpreted with caution. The study findings are depend-
ent on data recorded in the error reports by the individual 
reporter, which are potentially subject to reporter bias by 
either under-reporting or selective reporting. Furthermore, 
as the study was conducted within HMC, the findings 
may not be generalisable to either settings within Qatar or 
beyond.
Conclusion
While the medication error incidence rate in this study is 
lower than many other studies, almost all reports were sub-
mitted by pharmacists, indicating likely under-reporting. 
Effort is required to increase the effectiveness and efficiency 
of the reporting system. The use of the theoretical frame-
work allowed identification of potential causes in relation 
to active failures, which can form the basis of interventions 
to improve medication safety.
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